Becker's Healthcare May 17, 2024
Amgen’s Imdelltra is the first and only T-cell engager therapy approved for extensive-stage small cell lung cancer, an aggressive, stubborn cancer that spreads through the body.
On May 16, the FDA granted Imdelltra an accelerated approval. In a trial with 99 study participants with symptomatic brain metastases,...